MMP9 and neoplasm: Similarly, IL-33 affects the progression of malignant melanoma cells by binding to its receptor ST2 and inducing tumor cell proliferation, migration, and invasion through MMP-2, MMP-9, and ERK1/2 phosphorylation [79].